Originally published by our sister publication Specialty Pharmacy Continuum
Sickle cell disease (SCD) causes significant pain and other complications among approximately 100,000 U.S. residents and conveys a median life expectancy of 43 years (J Hematol Oncol 2022;15[1]:20). Despite those sobering statistics, pharmacists can still make a difference by educating patients about the importance of drug adherence, the pros and cons of newer therapies, and how to navigate drug coverage